The evolution of commercial drug delivery technologies
By Ava M. Vargason, A. Anselmo, S. Mitragotri. Nature Biomedical Engineering, 2021
1,037 citations recorded by the source corpus.
Subfields: Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/70b8fdec98817839548023fa59a127540bd3d659
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- J. O. Ogbodo
- Lulu Cai
- Rehmat Islam
- Yangbao Miao
- Evaristus Chinonso Odoh
- S. C. Eze
- Ugochukwu Solomon Okpala
- Charles Chinkwere Okoroafor
Citations in the corpus
- Smart nanoparticles for cancer therapy (2023, background): “276 In order to achieve these goals, researchers and medical experts have established various methods to overcome the inherent defects of current drugs.”
- Advances in drug delivery systems, challenges and future directions (2023, background): “Furthermore, it improves drug solubility, target site accumulation, efficacy, pharmacological activity, pharmacokinetic properties, patient acceptance, and compliance, and reduces drug toxicity [2].”